Neuphoria Therapeutics Inc (NEUP)

01:29 AM

How supply chain issues affect Neuphoria Therapeutics Inc. stockFed Meeting & Advanced Technical Analysis Signals - newser.com

01:29 AM

10:05 AM

Will Neuphoria Therapeutics Inc. stock continue upward momentumJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com

10:05 AM

Nov 17, 2025

Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 17, 2025

Nov 17, 2025

How to read the order book for Neuphoria Therapeutics Inc.Quarterly Trade Review & High Conviction Buy Zone Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

Is Neuphoria Therapeutics Inc. meeting your algorithmic filter criteriaTrend Reversal & Reliable Trade Execution Plans - newser.com

Nov 17, 2025

Nov 16, 2025

What Wall Street predicts for Neuphoria Therapeutics Inc. stock price2025 Price Momentum & AI Enhanced Trading Signals - newser.com

Nov 16, 2025

Nov 16, 2025

Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Fed Impact & Precise Buy Zone Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Is Neuphoria Therapeutics Inc. still worth holding after the dipJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

What does recent volatility data suggest for Neuphoria Therapeutics Inc.July 2025 Pullbacks & Pattern Based Trade Signal System - newser.com

Nov 16, 2025

Nov 16, 2025

Can Neuphoria Therapeutics Inc. stock maintain operating marginsTrade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com

Nov 16, 2025

Nov 15, 2025

Is Neuphoria Therapeutics Inc. stock attractive after correctionJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com

Nov 15, 2025

Nov 15, 2025

What indicators show strength in Neuphoria Therapeutics Inc.2025 Volatility Report & AI Driven Stock Movement Reports - newser.com

Nov 15, 2025

Nov 14, 2025

Neuphoria Therapeutics may offer & sell common stock of up to $20 million from time to timeSEC filing - MarketScreener

Nov 14, 2025

Nov 14, 2025

Can Neuphoria Therapeutics Inc. stock hit analyst price targetsAnalyst Downgrade & Real-Time Price Movement Reports - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

Will Neuphoria Therapeutics Inc. stock deliver shareholder value2025 Analyst Calls & Accurate Entry and Exit Point Alerts - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

Neuphoria Therapeutics Inc. SEC 10-Q Report - TradingView

Nov 14, 2025

Nov 13, 2025

Is Neuphoria Therapeutics Inc. showing signs of accumulation2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com

Nov 13, 2025

Nov 13, 2025

Combining price and volume data for Neuphoria Therapeutics Inc.Portfolio Value Report & AI Powered Buy/Sell Recommendations - newser.com

Nov 13, 2025

Nov 13, 2025

Will Neuphoria Therapeutics Inc. stock attract more institutional investors2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com

Nov 13, 2025

Nov 13, 2025

What analysts say about Neuphoria Therapeutics Inc stockRSI Overbought/Oversold & Free Smart Trading Classes - earlytimes.in

Nov 13, 2025

Nov 12, 2025

Neuphoria Files a Preliminary Proxy Statement with Securities and Exchange Commission - MarketScreener

Nov 12, 2025

Nov 12, 2025

NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - Stocktwits

Nov 12, 2025

Nov 11, 2025

Neuphoria Announces Receipt of Nomination Notice from Lynx1 Master - MarketScreener

Nov 11, 2025

Nov 11, 2025

Why hedge funds are buying Neuphoria Therapeutics Inc. stockMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com

Nov 11, 2025

Nov 11, 2025

Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value - MSN

Nov 11, 2025

Nov 11, 2025

Neuphoria announces initiation of strategic review - MarketScreener

Nov 11, 2025

Nov 11, 2025

Neuphoria Therapeutic (NEUP) Explores Strategic Options and Faces Acquisition Interest - GuruFocus

Nov 11, 2025

Nov 11, 2025

Neuphoria stock rises after initiating strategic review By Investing.com - Investing.com Canada

Nov 11, 2025

Nov 11, 2025

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value - Bluefield Daily Telegraph

Nov 11, 2025

Nov 11, 2025

Neuphoria (NASDAQ: NEUP) receives $5.20/share non-binding interest, engages H.C. Wainwright - Stock Titan

Nov 11, 2025

Nov 10, 2025

Lynx1 Capital Nominates Candidates to Neuphoria Therapeutics Board - MarketScreener

Nov 10, 2025